Results of treatment of patients with second- to third-stage breast cancer by combination of low-level laser therapy (LLLT) and surgery: ten-year experience

Laser therapy with semiconductor laser was performed on 41 patients with 2nd-3rd stage breast cancer. LLLT was used before surgery and in postoperative during 2 years. LLLT decreased postoperative complications by 15.3 percent and decreased duration of limphorrhea. 86.9 percent of patients with 2nd stage breast cancer survived 10 years after LLLT treatment. For patients with III stage breast cancer treated by LLLT the rate was 83.3 percent. 82.6 percent of patients with 2nd stage treated by LLLT had no recurrences in 10 years period. 77.7 percent of patients with 3RD stage treated by LLLT had no recurrences for the same period of time.